Journal
CLINICAL CANCER RESEARCH
Volume 15, Issue 15, Pages 4787-4789Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-09-0902
Keywords
-
Categories
Funding
- NCI NIH HHS [R01 CA177875, L30 CA117002, L30 CA117002-01] Funding Source: Medline
Ask authors/readers for more resources
The field of antiangiogenesis research has been met with some surprises, including the realization that tumor blood vessels are more complex and labile than expected. In this issue of Clinical Cancer Research, Xiong and colleagues show that tumor-specific endothelial cells are less sensitive to cytotoxic and antiangiogenic drugs compared to their normal counterparts.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
